Antibody Production Market Will Generate New Growth Opportunities By 2023

The rising incidence of infectious diseases worldwide, coupled with the growing demand for protein therapeutics, is supporting the progress of the global antibody production market. The commercial and clinical success of monoclonal antibodies has created the need for large-scale production of antibodies in mammalian cell culture.

Get Report Brochure @

The host proteins produced by the immune system as a response to foreign molecules which enter the body are known as antibodies. The entrance of foreign molecules, called antigens, is registered by the immune system, and it begins selective production of antibodies that are capable of binding the antigens. This natural ability of producing antibodies that can bind antigens can be harnessed in the manufacturing of probes to detect specific molecules of interest across a broad spectrum of diagnostic applications and research.

Till date, there is no other technology that offers researchers scope for designing and manufacturing such highly useful molecular recognition tools. The global market for antibody production has been broadly segmented by geography, application, and type.

The key growth drivers, challenges, trends, and opportunities in the global market for antibody production have been analyzed in detail in the report. Mapping the progress of the leading market players, the competitive landscape of the global antibody production market has been discussed wherein the major growth strategies of the market players, their market shares and product portfolios have been discussed. The analysts have leveraged the Porter’s Five Force analysis for the same.

View Report @

Antibody Production Market: Widespread Research Makes North America Lead with Maximum Revenue, says TMR

A report by Transparency Market Research, titled, “Antibody Production Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023,” speculates a polished future for this market and projects handsome revenue statistics to exist in the upcoming years.

Get Report Brochure @

The spread of infectious diseases are extensively increasing due to various reasons such as unhygienic lifestyles, rapid transmission of causative agents from person to person, and existence of climatic conditions favorable for the formation of pathogens. This has increased the rate at which antibodies need to be produced while carrying out relevant treatment processes, thus driving the relevant market. Those affected by deadly diseases are progressively opting for targeted immunotherapy which mainly deals with culturing antibodies to fight the harmful pathogens. Such preferences are gradually leading towards being beneficial for the global antibody production market’s growth. High focus put by market players on improving antibody culturing processes also is a prime boosting factor for the market.

The global antibody production market is divided into many segments based on type, application, and region. From a regional perspective, the market extends across Europe, Asia Pacific, North America, and Rest of the World. As a result of widespread research carried out by biotechnology and pharmaceutical businesses in North America, this region is crowned as a winner in terms of market’s presence and revenue generated.

A multitude of businesses working in the global antibody production market has led towards a highly fragmented layout of the vendor landscape over here. Talking about prime strategies, most players in the market put a lot of emphasis on strategic collaborations, mergers and acquisition, and attempting regional expansions. A prime example of such acquisition involves Merck buying out Sigma Aldrich Corp. in 2015. Eli Lilly and Company, Abbott Laboratories, GE Healthcare, Thermo Fisher Scientific, GeneTex, Inc., INTEGRA Biosciences AG, Abcam plc Roche Diagnostics Corporation, Pall Corp, Eppendorf AG, Merck Millipore, and Genentech are some of the key players operating in this market.

View Report @